Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study

Patrick Ott; Emiliano Calvo; Padmanee Sharma; Dirk Jaeger; Paolo Ascierto; Ian Chau; Johanna Bendell; Katriina Peltola; Matthew Taylor; Marina Tschaika; Cecile Dorange; Yelena Janjigian; Dung Le

doi:10.1093/annonc/mdx262.006

Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study

Patrick Ott, Emiliano Calvo, Padmanee Sharma, Dirk Jaeger, Paolo Ascierto, Ian Chau, Johanna Bendell, Katriina Peltola, Matthew Taylor, Marina Tschaika, Cecile Dorange, Yelena Janjigian, Dung Le

Hematology & Medical Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	iii139
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx262.006
State	Published - Jun 1 2017

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdx262.006

Cite this

Ott, P., Calvo, E., Sharma, P., Jaeger, D., Ascierto, P., Chau, I., Bendell, J., Peltola, K., Taylor, M., Tschaika, M., Dorange, C., Janjigian, Y., & Le, D. (2017). Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study. Annals of oncology : official journal of the European Society for Medical Oncology, 28, iii139. https://doi.org/10.1093/annonc/mdx262.006

Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study. / Ott, Patrick; Calvo, Emiliano; Sharma, Padmanee et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, 01.06.2017, p. iii139.

Research output: Contribution to journal › Article › peer-review

Ott, P, Calvo, E, Sharma, P, Jaeger, D, Ascierto, P, Chau, I, Bendell, J, Peltola, K, Taylor, M, Tschaika, M, Dorange, C, Janjigian, Y & Le, D 2017, 'Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. iii139. https://doi.org/10.1093/annonc/mdx262.006

Ott P, Calvo E, Sharma P, Jaeger D, Ascierto P, Chau I et al. Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study. Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Jun 1;28:iii139. doi: 10.1093/annonc/mdx262.006

@article{1d83d077dbd84584b805255791d2ab6a,

title = "Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study",

author = "Patrick Ott and Emiliano Calvo and Padmanee Sharma and Dirk Jaeger and Paolo Ascierto and Ian Chau and Johanna Bendell and Katriina Peltola and Matthew Taylor and Marina Tschaika and Cecile Dorange and Yelena Janjigian and Dung Le",

year = "2017",

month = jun,

day = "1",

doi = "10.1093/annonc/mdx262.006",

language = "English (US)",

volume = "28",

pages = "iii139",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens

T2 - Sub-analysis of the CheckMate 032 study

AU - Ott, Patrick

AU - Calvo, Emiliano

AU - Sharma, Padmanee

AU - Jaeger, Dirk

AU - Ascierto, Paolo

AU - Chau, Ian

AU - Bendell, Johanna

AU - Peltola, Katriina

AU - Taylor, Matthew

AU - Tschaika, Marina

AU - Dorange, Cecile

AU - Janjigian, Yelena

AU - Le, Dung

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85061184748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061184748&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx262.006

DO - 10.1093/annonc/mdx262.006

M3 - Article

SN - 0923-7534

VL - 28

SP - iii139

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this